Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Atrial Fibrillation
68%
Catheter Ablation
61%
Heart Failure with Preserved Ejection Fraction (HFpEF)
50%
Reduced Ejection Fraction
47%
Heart Failure Patients
45%
Sacubitril/valsartan
45%
Heart Failure
39%
Taiwan
34%
Taiwan Society of Cardiology
30%
Patients with Heart Failure
30%
Left Ventricular Ejection Fraction
27%
Clinical Outcomes
24%
Paroxysmal Atrial Fibrillation
23%
Ablation
22%
Ivabradine
19%
Heart Failure Therapy
17%
Heart Failure Hospitalization
17%
Atrial Arrhythmias
16%
Atrial Fibrillation Ablation
15%
Ganglionated Plexi
14%
Atrial Fibrillation Patient
13%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
13%
Cardiovascular Mortality
13%
Superior Vena Cava
11%
Angiotensin Receptor-neprilysin Inhibitor
11%
CHA2DS2-VASc Score
11%
Electrocardiogram
10%
Acute Decompensated Heart Failure
10%
Cardiac Resynchronization Therapy
10%
Cardiovascular Outcomes
10%
Baseline Characteristics
9%
Heart Disease Diagnosis
9%
Atrium
9%
Atrial Substrate
9%
Iron Deficiency
9%
Systolic Heart Failure
9%
Cost-effectiveness Evaluation
9%
Sleep Apnea Detection
9%
Health Systems
9%
Cardiac Autonomic Function
9%
Patient Perception
9%
Angiotensin
9%
Intravenous Iron Sucrose
9%
Evolocumab
9%
Low-density Lipoprotein Cholesterol (LDL-C)
9%
Cholesterol Reduction
9%
Persistent Atrial Fibrillation
9%
Atrial Flutter
8%
Metformin
8%
Heart Rate
8%
Medicine and Dentistry
Ablation
78%
Atrial Fibrillation
76%
Congestive Heart Failure
73%
Ejection Fraction
47%
Heart Failure with Reduced Ejection Fraction
35%
Sacubitril
26%
Valsartan
26%
Cardiology
26%
Recurrent Disease
19%
Superior Vena Cava
18%
Heart Left Ventricle Ejection Fraction
15%
Ivabradine
15%
Electrocardiography
14%
Iron Deficiency
13%
Electrocardiogram
13%
Heart Transplantation
12%
Long-Term Outcome
11%
Angiotensin Receptor
11%
Enkephalinase Inhibitor
11%
Cardiovascular System
11%
Heart Ventricle Remodeling
10%
Acute Decompensated Heart Failure
10%
Tachyarrhythmia
10%
Atrium
10%
Cardiac Resynchronization Therapy
9%
Health Care Cost
9%
Atrial Flutter
9%
Electrography
9%
ST Segment Elevation Myocardial Infarction
9%
Systolic Heart Failure
9%
Angiotensin
9%
Iron Sucrose
9%
Diabetes
8%
Paroxysmal Atrial Fibrillation
8%
Pulmonary Vein Isolation
7%
Mortality Rate
7%
Persistent Atrial Fibrillation
7%
Hypertension
7%
Prevalence
7%
Sudden Cardiac Death
6%
Supraventricular Tachycardia
6%
Ferritin
6%
Apoplexy
6%
Etiology
6%
CHADS2 Score
5%
Atrioventricular Nodal Reentry Tachycardia
5%
Antiarrhythmic Agent
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Sodium-Glucose Cotransporter 2 Inhibitors
5%
Cardiac Dysrhythmia
5%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Valsartan/Sacubitril
58%
Atrial Fibrillation
49%
Heart Failure with Reduced Ejection Fraction
47%
Ivabradine
23%
sodium glucose cotransporter-2 inhibitors
15%
Cardiovascular Risk
11%
Sodium Glucose Cotransporter 2 Inhibitor
10%
Observational Study
10%
Angiotensin Receptor
10%
Heart Ventricle Remodeling
10%
Metformin
9%
Low Density Lipoprotein Cholesterol
9%
Evolocumab
9%
Sodium Glucose Cotransporter 2
9%
All Cause Mortality
8%
Cerebrovascular Accident
8%
Prevalence
7%
Enkephalinase Inhibitor
6%
Chronic Kidney Failure
6%
Heart Atrium Remodeling
6%
Acute Heart Failure
6%
Mortality Rate
5%
Beta Adrenergic Receptor Blocking Agent
5%
Heart Left Ventricle Failure
5%
Sudden Death
5%
Etiology
5%
Cohort Study
5%
Thromboembolism
5%
Adverse Event
5%
Hypertension
5%
Hypotension
5%
Sleep Disordered Breathing
5%
Angiotensin
5%